Société Française d'Oncologie Pédiatrique Selected Research

LMB89 protocol

5/2002	Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.
6/2001	The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Société Française d'Oncologie Pédiatrique Research Topics

Disease

3	Leukemia 03/2003 - 06/2001
3	Neoplasms (Cancer) 03/2003 - 06/2001
2	B-Cell Lymphoma (Lymphoma, B Cell) 05/2002 - 06/2001
1	Hodgkin Disease (Hodgkin's Disease) 03/2003
1	Osteosarcoma (Osteogenic Sarcoma) 03/2003
1	Hyperphosphatemia 05/2002
1	Hemolysis 05/2002
1	Hypersensitivity (Allergy) 05/2002
1	Hypocalcemia 05/2002
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2002
1	Water Intoxication 05/2002
1	Tumor Lysis Syndrome 05/2002
1	Hyperuricemia 05/2002
1	Burkitt Lymphoma (Burkitt's Lymphoma) 06/2001
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2001

Drug/Important Bio-Agent (IBA)

2	Etoposide (VP 16)FDA LinkGeneric 03/2003 - 06/2001
1	Alkylating AgentsIBA 03/2003
1	AnthracyclinesIBA 03/2003
1	EWS-FLI fusion proteinIBA 01/2003
1	CreatinineIBA 05/2002
1	Urate Oxidase (Uricase)IBA 05/2002
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2001
1	Methotrexate (Mexate)FDA LinkGeneric 06/2001

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 03/2003 - 06/2001
2	LMB89 protocol 05/2002 - 06/2001
1	Radiotherapy 03/2003